Publications by authors named "Wan-Lan Bo"
Article Synopsis
- The study investigates the effects of geraniol acetate (gefarnate) in reducing lipid levels in patients with coronary artery disease (CAD) who still experience high triglycerides after statin treatment.
- Patients in a trial received either gefarnate with statins or just statins, and results showed significant reductions in triglyceride and increases in HDL cholesterol after one month of treatment with gefarnate.
- These findings suggest that gefarnate might help manage CAD by lowering harmful lipid levels while simultaneously protecting against gastrointestinal injuries caused by aspirin.
Purpose: High on-treatment platelet reactivity (HTPR) after clopidogrel administration in patients with acute coronary syndrome (ACS) has been associated with an increased risk of adverse events. Our previous studies reported that half-dose ticagrelor provides a similar inhibitory effect on adenosine diphosphate (ADP)-induced platelet aggregation as standard-dose ticagrelor, but half-dose of ticagrelor has not been studied in Chinese ACS patients with HTPR. This study aimed to compare the antiplatelet action of half-dose ticagrelor with high-dose clopidogrel in ACS patients with HTPR.
View Article and Find Full Text PDF